查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611385

无血清培养基市场：按产品类型、最终用户、应用划分 - 2025-2030 年全球预测

Serum-Free Media Market by Product (BHK Medium, CHO Media, HEK 293 Media), Type (Liquid Media, Semi-solid & Solid Media), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年无血清培养基市场价值为15.2亿美元，预计到2024年将达到16.8亿美元，复合年增长率为11.35%，到2030年将达到32.3亿美元。

无血清培养基是指不含动物血清的细胞培养基配方，动物血清传统上是生长因子、荷尔蒙和其他重要营养素的来源。由于生物製药、疫苗开发和再生医学的进步，无血清培养基的使用范围呈指数级扩大，因为其一致性、污染风险降低和伦理考量。对无血清培养基的需求源于对可重复且可靠的研究结果的高要求、对动物性成分安全性的担忧以及对明确製造流程的监管要求。其应用在用于重组蛋白生产、单株抗体生产和干细胞培养的哺乳动物细胞培养中具有重要意义。最终用途领域包括生物技术公司、製药公司、研究机构和临床实验室。影响该市场的主要成长要素包括细胞培养技术的技术进步、生物製药产量的增加以及细胞研究投资的增加。合成、植物或重组补充剂的最新趋势进一步扩大了市场，从而创造了针对特定细胞株或治疗应用的经济高效、可扩展和可自订的培养基解决方案。无血清配方的高成本、最佳细胞培养所需的技术专业知识以及生产中的扩充性和产量问题等挑战阻碍了一些市场的引入。为了解决这些问题，公司可以透过开发先进的多功能培养基配方和自动化工具来简化细胞培养过程进行创新。 CRISPR、3D 细胞培养和生物工程组织等新兴领域有望透过整合无血清培养基解决方案实现创新。为了实现永续成长，公司应该投资于合作研究，利用伙伴关係关係来降低开发成本，并专注于个人化医疗中未满足的需求。整体而言，无血清培养基市场可望成长，但需要对创新进行策略性投资，以有效应对根本挑战。

主要市场统计
基准年[2023] 15.2亿美元
预计年份 [2024] 16.8亿美元
预测年份 [2030] 32.3亿美元
复合年增长率（%） 11.35%

市场动态：快速发展的无血清培养基市场的关键市场洞察

无血清培养基市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 增加单株抗体、疫苗和重组蛋白的产量
    • 增加政府对干细胞研究的投资与倡议
  • 市场限制因素
    • 营养限制和细胞增殖减少
  • 市场机会
    • 学术界与生物科技公司合作客製化无血清培养基产品
    • 生物加工技术和分析工具的进步
  • 市场挑战
    • 设计和优化无血清培养基的复杂性

驾驭波特五力无血清培养基市场的策略工具

波特的五力架构是了解无血清培养基市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解无血清培养基市场的外部影响

外部宏观环境因素在塑造无血清培养基市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解无血清培养基市场的竞争状况

无血清培养基市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵无血清培养基市场供应商绩效评估

FPNV定位矩阵是评估无血清培养基市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了无血清培养基市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对无血清媒体市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加单株抗体、疫苗和重组蛋白的产量
      • 增加政府对干细胞研究的投资与承诺
    • 抑制因素
      • 营养限制和细胞增殖减少
    • 机会
      • 透过学术界和生物技术公司之间的合作客製化无血清培养基产品
      • 生物加工技术和分析工具的进步
    • 任务
      • 设计和优化无血清培养基的复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章无血清培养基市场：副产品

  • BHK中型
  • CHO媒体
  • HEK 293 媒体
  • 干细胞培养基
  • 贝洛中型

第七章无血清媒体市场：依类型

  • 液体介质
  • 半固态和固态介质

第 8 章 无血清媒体市场：依最终用户分类

  • 製药和生物技术公司
  • 研究/学术机构

第 9 章 无血清培养基市场：依应用

  • 生物製药製造
    • 单株抗体
    • 疫苗生产
  • 组织工程与再生医学

第10章美洲无血清培养基市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太血清自由媒体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的无血清培养基市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Ajinomoto Co., Inc.
  • ATZ Labz by Life Technologies（India）Pvt Ltd.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biowest
  • Celprogen Inc.
  • Corning Incorporated
  • Danahar Corporation
  • FUJIFILM Holdings Corporation
  • Fukoku Co., Ltd.
  • Gmep Incorporated
  • HiMedia Laboratories.
  • Jimi Biotech
  • Kyokuto Pharmaceutical Industrial Co., Ltd
  • Leinco Technologies, Inc.
  • Lonza Group
  • Merck KgaA
  • Myoridge Co. Ltd.
  • Nucleus Biologics
  • PAN-Biotech GmbH
  • R&D Systems, Inc.
  • REPROCELL Inc.
  • Sartorius AG
  • Shanghai BioEngine Sci-Tech Co, Ltd
  • Shanghai Excell Biological Technology Co., Ltd.
  • Sino Biological, Inc.
  • STEMCELL Technologies Canada Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • ZenBio, Inc.
Product Code: MRR-7C31448F0BA9

The Serum-Free Media Market was valued at USD 1.52 billion in 2023, expected to reach USD 1.68 billion in 2024, and is projected to grow at a CAGR of 11.35%, to USD 3.23 billion by 2030.

Serum-free media refer to cell culture media formulations that do not contain animal serum, which is traditionally a source of growth factors, hormones, and other vital nutrients. The scope of serum-free media has expanded tremendously with advancements in biopharmaceutical production, vaccine development, and regenerative medicine due to their consistency, reduced risk of contamination, and ethical considerations. The necessity for serum-free media stems from the high demand for reproducible and reliable research results, safety concerns with animal-derived components, and regulatory demands for well-defined manufacturing processes. Its application is crucial in cultivating mammalian cells for recombinant protein production, monoclonal antibody generation, and stem cell culture. End-use sectors include biotech firms, pharmaceuticals, research institutions, and clinical laboratories. Key growth factors influencing this market include technological advancements in cell culture techniques, increasing biopharmaceutical production, and rising investment in cell-based research. Recent developments in synthetic, plant-based, or recombinant supplementation further expand the market, offering new business opportunities focused on creating cost-effective, scalable, and customizable media solutions tailored to specific cell lines or therapy applications. Challenges such as the high cost of serum-free formulations, technical expertise required for optimal cell cultivation, and issues related to scalability and yield in production have impeded some market adoption. To counter these, firms could innovate by developing advanced, multifunctional media formulations or automation tools that streamline cell culture processes. Emerging areas such as CRISPR, 3D cell culture, and bio-engineered tissues present prospects for innovation by integrating serum-free media solutions. For sustained growth, businesses should invest in collaborative research, leverage partnerships to reduce development costs, and focus on the unmet needs of personalized medicine. Overall, the serum-free media market is poised for growth but necessitates strategic investments in innovation to effectively address underlying challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 1.52 billion
Estimated Year [2024] USD 1.68 billion
Forecast Year [2030] USD 3.23 billion
CAGR (%) 11.35%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Serum-Free Media Market

The Serum-Free Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing production of monoclonal antibodies, vaccines, and recombinant proteins
    • Rising government investment and initiatives for stem cell research
  • Market Restraints
    • Nutrient limitations and reduced cell proliferation
  • Market Opportunities
    • Collaboration among academia and biotech firms to customize serum-free media products
    • Advancements in bioprocess technology and analytical tools
  • Market Challenges
    • Complexity of designing and optimizing serum-free media

Porter's Five Forces: A Strategic Tool for Navigating the Serum-Free Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Serum-Free Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Serum-Free Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Serum-Free Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Serum-Free Media Market

A detailed market share analysis in the Serum-Free Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Serum-Free Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Serum-Free Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Serum-Free Media Market

A strategic analysis of the Serum-Free Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Serum-Free Media Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., ATZ Labz by Life Technologies (India) Pvt Ltd., Becton, Dickinson and Company, Bio-Techne Corporation, Biowest, Celprogen Inc., Corning Incorporated, Danahar Corporation, FUJIFILM Holdings Corporation, Fukoku Co., Ltd., Gmep Incorporated, HiMedia Laboratories., Jimi Biotech, Kyokuto Pharmaceutical Industrial Co., Ltd, Leinco Technologies, Inc., Lonza Group, Merck KgaA, Myoridge Co. Ltd., Nucleus Biologics, PAN-Biotech GmbH, R&D Systems, Inc., REPROCELL Inc., Sartorius AG, Shanghai BioEngine Sci-Tech Co, Ltd, Shanghai Excell Biological Technology Co., Ltd., Sino Biological, Inc., STEMCELL Technologies Canada Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Serum-Free Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across BHK Medium, CHO Media, HEK 293 Media, Stem Cell Medium, and Vero Medium.
  • Based on Type, market is studied across Liquid Media and Semi-solid & Solid Media.
  • Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research & Academic Institutes.
  • Based on Application, market is studied across Biopharmaceutical Production and Tissue Engineering & Regenerative Medicine. The Biopharmaceutical Production is further studied across Monoclonal Antibodies and Vaccines Production.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing production of monoclonal antibodies, vaccines, and recombinant proteins
      • 5.1.1.2. Rising government investment and initiatives for stem cell research
    • 5.1.2. Restraints
      • 5.1.2.1. Nutrient limitations and reduced cell proliferation
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaboration among academia and biotech firms to customize serum-free media products
      • 5.1.3.2. Advancements in bioprocess technology and analytical tools
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity of designing and optimizing serum-free media
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Serum-Free Media Market, by Product

  • 6.1. Introduction
  • 6.2. BHK Medium
  • 6.3. CHO Media
  • 6.4. HEK 293 Media
  • 6.5. Stem Cell Medium
  • 6.6. Vero Medium

7. Serum-Free Media Market, by Type

  • 7.1. Introduction
  • 7.2. Liquid Media
  • 7.3. Semi-solid & Solid Media

8. Serum-Free Media Market, by End-User

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research & Academic Institutes

9. Serum-Free Media Market, by Application

  • 9.1. Introduction
  • 9.2. Biopharmaceutical Production
    • 9.2.1. Monoclonal Antibodies
    • 9.2.2. Vaccines Production
  • 9.3. Tissue Engineering & Regenerative Medicine

10. Americas Serum-Free Media Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Serum-Free Media Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Serum-Free Media Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Co., Inc.
  • 2. ATZ Labz by Life Technologies (India) Pvt Ltd.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Techne Corporation
  • 5. Biowest
  • 6. Celprogen Inc.
  • 7. Corning Incorporated
  • 8. Danahar Corporation
  • 9. FUJIFILM Holdings Corporation
  • 10. Fukoku Co., Ltd.
  • 11. Gmep Incorporated
  • 12. HiMedia Laboratories.
  • 13. Jimi Biotech
  • 14. Kyokuto Pharmaceutical Industrial Co., Ltd
  • 15. Leinco Technologies, Inc.
  • 16. Lonza Group
  • 17. Merck KgaA
  • 18. Myoridge Co. Ltd.
  • 19. Nucleus Biologics
  • 20. PAN-Biotech GmbH
  • 21. R&D Systems, Inc.
  • 22. REPROCELL Inc.
  • 23. Sartorius AG
  • 24. Shanghai BioEngine Sci-Tech Co, Ltd
  • 25. Shanghai Excell Biological Technology Co., Ltd.
  • 26. Sino Biological, Inc.
  • 27. STEMCELL Technologies Canada Inc.
  • 28. Thermo Fisher Scientific Inc.
  • 29. TransGen Biotech Co., Ltd.
  • 30. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. SERUM-FREE MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. SERUM-FREE MEDIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SERUM-FREE MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SERUM-FREE MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BHK MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY HEK 293 MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VERO MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY SEMI-SOLID & SOLID MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VACCINES PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 234. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023